Free Trial

Tilray Brands (NASDAQ:TLRY) Shares Up 4% - What's Next?

Tilray Brands logo with Medical background

Tilray Brands, Inc. (NASDAQ:TLRY - Get Free Report)'s share price rose 4% during mid-day trading on Thursday . The stock traded as high as $0.62 and last traded at $0.63. Approximately 6,831,671 shares were traded during mid-day trading, a decline of 78% from the average daily volume of 31,133,703 shares. The stock had previously closed at $0.60.

Analyst Ratings Changes

Several research analysts recently commented on the stock. Wall Street Zen downgraded shares of Tilray Brands to a "strong sell" rating in a research note on Saturday, July 5th. Roth Capital reaffirmed a "neutral" rating on shares of Tilray Brands in a research report on Monday, April 14th. Finally, Piper Sandler dropped their price objective on shares of Tilray Brands from $2.00 to $1.00 and set a "neutral" rating on the stock in a report on Wednesday, April 9th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $1.92.

Check Out Our Latest Analysis on Tilray Brands

Tilray Brands Price Performance

The company has a quick ratio of 1.61, a current ratio of 2.62 and a debt-to-equity ratio of 0.12. The stock's 50-day simple moving average is $0.46 and its two-hundred day simple moving average is $0.69. The company has a market capitalization of $626.04 million, a price-to-earnings ratio of -0.59 and a beta of 1.82.

Institutional Investors Weigh In On Tilray Brands

Hedge funds have recently modified their holdings of the company. Lido Advisors LLC purchased a new stake in shares of Tilray Brands in the fourth quarter valued at about $28,000. Dudley Capital Management LLC purchased a new stake in Tilray Brands in the 4th quarter valued at about $29,000. Cerity Partners LLC purchased a new position in Tilray Brands during the first quarter worth about $31,000. Capital Management Associates Inc boosted its stake in Tilray Brands by 100.0% during the first quarter. Capital Management Associates Inc now owns 50,760 shares of the company's stock worth $33,000 after buying an additional 25,380 shares during the period. Finally, Fifth Lane Capital LP boosted its stake in Tilray Brands by 400.0% during the first quarter. Fifth Lane Capital LP now owns 50,000 shares of the company's stock worth $33,000 after buying an additional 40,000 shares during the period. Hedge funds and other institutional investors own 9.35% of the company's stock.

Tilray Brands Company Profile

(Get Free Report)

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.

Featured Stories

Should You Invest $1,000 in Tilray Brands Right Now?

Before you consider Tilray Brands, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray Brands wasn't on the list.

While Tilray Brands currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters
This Strategy Beat the S&P—And Most Investors Ignore It
NVDA Greenlight: China Sales Spark 50% Rally Potential

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines